Javier-David Benitez-Fuentes

21PUBLICATIONS
45CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Rural and remote health servicesPredictive and prognostic markersMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 28, 2026
ALK ATI in solid tumours: biological evidence, diagnostic challenges, and clinical relevance. a narrative review.

|Sep 06, 2026
Baseline Gustave Roussy Immune Score and Survival in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemoimmunotherapy.

|Jul 28, 2026
Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG Study.

|Jun 23, 2026
Geographic access as a modifiable determinant of cancer care: perspectives on hub-and-spoke oncology networks, travel burden and time toxicity.

|Jan 10, 2026
Perceptions of social determinants influencing cancer development, outcomes, and treatment toxicity among Spanish oncologists, nurses, and pharmacists: a cross-sectional survey.

Javier-David Benítez-Fuentes, Regina Gironés Sarrió, Victoria García Samblás

|Aug 29, 2025
Adding Docetaxel to Tepotinib to Overcome Oligoprogression in MET Exon 14 Skipping-Mutated NSCLC When Local Therapy Is Unfeasible: A Case Report.

David Sánchez García, Beatriz Grau Mirete, Paula Rodríguez Payá

Pageof 4

Frequent Collaborators

6 joint publications

Miguel Borregón-Rivilla

5 joint publications

Alvaro Rodriguez-Lescure

4 joint publications

Asia Ferrández-Arias

4 joint publications

Alicia Milagros de Luna Aguilar